Abstract:Objective: To study the inflammation response and the biocompatibility of valved bovine jugular vein conduit (BJVC) and valved bovine jugular vein patch (VBJV-P) in treating complex congenital heart disease (CHD). Methods: From December 2007 to March 2008, 16 patients with complex CHD were treated. Of 16 patients, 6 underwent conjunction right ventricular to pulmonary artery with BJVC and broaden right ventricular outflow tract (RVOT) with VBJV-P (BJVC group), and 10 underwent broaden RVOT with self pericardial patch (control group). In BJVC group, there were 3 males and 3 females, aging (5.6 +/- 3.6) years, and including 1 case of type I truncus arteriosus, 1 case of type I truncus arteriosus with ventricular septal defect and patent foramen ovale, 1 case of congenital pulmonary atresia with ventricular septal defect and patent arterial duct, and 3 cases of Fallot's tetrad. In control group, there were 5 males and 5 females, aging (4.3 +/- 3.1) years, all being Fallot's tetrad. The periphery vein blood of the two groups was collected during operation and after operation, and the levels of cytokine were detected with ELISA method. Meanwhile the clinical data of the two groups were collected. Results: There were no significant differences at levels of TNF-alpha and IL-6 between BJVC group and control group 1 week after operation (P > 0.05), and there was significant difference at level of IL-10 [(25.7 +/- 5.0) pg/mL vs (19.5 +/- 4.7) pg/mL, P < 0.05]. There were no significant differences at levels of IL-6 and IL-10 within groups botvin control group and in BJVC group (P > 0.05) between 1 week after operation and the anesthesia inducing period. And there was significant difference at level of TNF-alpha in BJVC group [(77.0 +/- 1.6) pg/mL vs (82.9 +/- 1.3) pg/mL, P < 0.05] and in control group [(78.6 +/- 3.4) pg/mL vs (83.1 +/- 1.9) pg/mL, P < 0.05] between 1 week after operation and the anesthesia inducing period. There were no statistically significant differences (P > 0.05) in leukocyte count and body temperature between BJVC group and control group. The X-ray films showed no abnormality in BJVC group and control group before operation and after operation. No hepatic and renal dysfunction occurred in control group; and 2 patients had hepatic dysfunction, which may be caused by antibiotics. Conclusion: BJVC has a good biocompatibility in treating complexity CHD.

Research on the anti-calcification property of bovine jugular vein conduit cross-linked by polyepoxy compound

[The Advantages of Bovine Jugular Vein Tanned with Hydrophilia Crosslinking Agent].

Reconstruction of Rat Abdominal Aota with Jugular Vein Homografts Pretreated by Polyepoxy Compound

Experimental Study on Cryopreserved Aortic Homograft Interposed in the Inferior Vena Cava in Canine

A New Method of Making Arterious Acellular Scaffold

Correction: Evaluation of a Novel Thermosensitive Heparin-Poloxamer Hydrogel for Improving Vascular Anastomosis Quality and Safety in a Rabbit Model.

Epoxy- versus Glutaraldehyde-Treated Bovine Jugular Vein Conduit for Pulmonary Valve Replacement: A Comparison of Morphological Changes in a Pig Model

Prevention of Tissue Calcification on Bioprosthetic Heart Valve by Using Epoxy Compounds: a Study of Calcification Tests in Vitro and in Vivo.

Study on Restoration of Canine Femoral Arteries with Allogenic Veins Pretreated by Polyepoxy Compounds

Anti-calcification effect of the cells in the small caliber tissue engineered vascular graft

Ulvan mediated VE cadherin antibody and REDV peptide co-modification to improve endothelialization potential of bioprosthetic heart valves

A Novel Detergent-Based Decellularization Combined with Carbodiimide Crosslinking for Improving Anti-Calcification of Bioprosthetic Heart Valve.

[Changes of seral TNF-alpha, IL-6 and IL-10 level after implantation of valved bovine jugular vein conduit in complex congenital heart diseases]

Curcumin-crosslinked acellular bovine pericardium for the application of calcification inhibition heart valves

Calcification of Various Bioprosthetic Materials in Rats: Is It Really Different?

[Histological Character of Intimal Hyperplasia Post Jugular Vein Grafts and the Protective Effect of Lovastatin].

Midterm Outcomes of Crosslinked Acellular Bovine Jugular Vein Conduit for Right Ventricular Outflow Tract Reconstruction

Experimental study of arterialized vein graft remodeling

The Effect of the Fibrin Glue Perivenous Support on the Prolifelation and Apoptosis of the Vascular Smooth Muscle Cells

Double crosslinking decellularized bovine pericardium of dialdehyde chondroitin sulfate and zwitterionic copolymer for bioprosthetic heart valves with enhanced antithrombogenic, anti-inflammatory and anti-calcification properties

Histological changes and comparisons of three great vessel substitutes after human implantation